期刊文献+

精准营养干预方案改善辅助化疗期胃癌和结直肠癌患者毒性反应、营养摄入和生活质量的效果观察 被引量:15

Precision nutrition intervention program improves toxicity,nutritional intake and quality of life of patients with gastric and colorectal cancer during adjuvant chemotherapy
下载PDF
导出
摘要 目的探讨辅助化疗期精准营养干预方案对改善胃癌、结直肠癌患者毒性反应、营养摄入和生活质量的影响。方法将150例胃癌、结直肠癌患者随机分为观察组和对照组各75例,观察组在辅助化疗期接受精准化的营养干预方案,对照组在辅助化疗期接受基础营养护理和健康教育,比较两组患者的胃肠道及血液毒性反应、营养状况和生活质量。结果观察组患者在T2周期胃肠道毒性反应中恶心和T3周期胃肠道毒性反应中恶心、呕吐、厌食发生率少于对照组,观察组患者在T3周期血液毒性反应中白细胞减少发生率对照组,两组比较,差异具有统计学意义(均P<0.01)。观察组在T3周期能量、蛋白质、体重改善程度均优于对照组(P<0.05),观察组患者生活质量的生理机能及生理职能维度在T3周期得分高于对照组。结论辅助化疗期精准营养干预方案能一定程度改善胃癌、结直肠癌患者胃肠道及血液毒性、营养摄入、生活质量,有利于提升患者治疗依从性及效果。 Objective To investigate the effect of a precision nutrition intervention program during adjuvant chemotherapy on toxic reactions,nutrition intake,and quality of life of patients with gastric and colorectal cancer. Methods A total of 150 patients with gastric and colorectal cancer were randomly divided equally into the intervention and control groups: in the former group the patients were managed with a precision nutrition intervention program during the adjuvant chemotherapy,and the latter with basic nutrition care and health education during the same period. The two groups were compared in terms of gastrointestinal and hematologic toxic effects,nutritional status,and quality of life. Results In the second cycle of adjuvant chemotherapy,the rate of nausea in the intervention group was lower than that in the control group(P<0.01) and so it was with the rates of gastrointestinal toxicities like nausea,vomiting,anorexia in the third cycle of adjuvant chemotherapy(P<0.01). The rate of leukopenia,the hematologic toxicity was significantly lower than that of the control group in the third cycle(P<0.01). During the third cycle,the intake of energy and protein and body weight in the intervention group were significantly improved as compared with the control group(P<0.05). The two dimensions of quality of life,e.g.,physical functioning and physical functioning in the intervention group were scored significantly higher than in the control during the third cycle( P < 0. 01). Conclusions The precision nutrition intervention program during the adjuvant chemotherapy can alleviate the gastrointestinal and hematological toxic reactions and improve the nutrition intake and quality of life of patients with gastric and colorectal cancer. It is beneficial for improving patient compliance and therapeutic efficacy.
作者 胡斐 杭凌 董志霞 Hu Fei;Hang Ling;Dong Zhi Xia(Department of Gastrointestinal Oncology Surgery,Jiangnan University Hospital,Wuxi 214000,China)
出处 《现代临床护理》 2021年第10期27-34,共8页 Modern Clinical Nursing
基金 无锡市卫健委适宜技术推广项目,项目编号为T202015。
关键词 癌症 化疗 精准营养 营养干预 毒性反应 cancer chemotherapy precision nutrition nutritional intervention toxicity
  • 相关文献

参考文献6

二级参考文献89

  • 1谢小亮,夏羽菡,李海,张东,杨银学.120例结直肠癌患者术前营养状态评估[J].宁夏医科大学学报,2013,35(10):1139-1141. 被引量:11
  • 2王晓娜,梁寒,王家仓,王宝贵.1829例结直肠癌患者的临床病理特征及预后分析[J].中华胃肠外科杂志,2004,7(6):439-442. 被引量:36
  • 3全应军,吴国豪,郑烈伟,吴肇汉.消化道肿瘤患者手术前后代谢改变研究[J].上海医学,2006,29(8):530-533. 被引量:5
  • 4吴蓓雯,曹伟新,费旭峰.328例消化道恶性肿瘤患者营养状况评价[J].上海交通大学学报(医学版),2007,27(5):604-606. 被引量:39
  • 5Smith BD,Smith GL, Hurria A,etal. Future of cancer incidence in the United States: Burdens upon an aging, changing nation[J]. J Clin Oncol,2009,27(17) :2758 - 2765.
  • 6Ware JE,Sherbourne CD. The MOS 36 - item short - form health survey (SF- 36): Conceptual framework and item selection[J]. Med Care,1992,30(6):473 -483.
  • 7Hays RD,Sherhourne CD,Mazel R. User's manual for the Medi- cal Outcomes Study (MOS) core measures of health - related quality of life[M]. Santa Monica, CA: RAND Corporation, 1995 : 1.
  • 8Pickard AS, Neary MP, Cella D. Estimation of minimally impor- tant differences in EQ- 5D utility and VAS scores in cancer [J]. Health and Quality of Life Outcomes, 2007,5 : 70.
  • 9Schipper H, Clinch J, McMurray A, et al. Measuring the quality of life of cancer patients: The Functional Living Index - Cancer: De- velopment and validation[J]. J Clin Oncol, 1984,2 (5) :472 - 483.
  • 10Cella DF,Tulsky DS,Gray G,et al. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure[J]. J Clin Onco1,1993,11(3) :570 - 579.

共引文献256

同被引文献157

引证文献15

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部